✦ LIBER ✦

THE COST-EFFECTIVENESS OF SOLIFENACIN VS FESOTERODINE, OXYBUTYNIN IMMEDIATE-RELEASE, PROPIVERINE, TOLTERODINE EXTENDED-RELEASE AND TOLTERODINE IMMEDIATE-RELEASE IN THE TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER IN THE UK NATIONAL HEALTH SERVICE

✍ Scribed by Juliet L. Warner

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cost-effectiveness of solifenacin vs

✍ Linda Cardozo; Andrew Thorpe; Juliet Warner; Manpreet Sidhu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

Canadian economic comparison of extended

✍ Denis Getsios; J.Jaime Caro; K.Jack Ishak; Wissam El-Hadi; Krista Payne 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Cost Effectiveness of Controlled-Release

✍ Dr Julian F. Guest, Dele Abegunde, Francis J. Ruiz 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 148 KB

PUK2 COST-EFFECTIVENESS ANALYSIS OF EXTE

✍ D Castro; J Soto; I Exposito 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PUK20 A COST EFFECTIVENESS ANALYSIS OF S

✍ HH Kang; JY Bae; SY Park; HS Sohn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PUK10 Cost-Effectiveness Analysis of Sol

✍ W.M. Hart; V. Munro; P. Retsa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB